The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells.

[1]  G. P. Studzinski,et al.  Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance , 2012, Cell cycle.

[2]  E. Kuranaga.  Beyond apoptosis: caspase regulatory mechanisms and functions in vivo , 2012, Genes to cells : devoted to molecular & cellular mechanisms.

[3]  H. Steller,et al.  Programmed Cell Death in Animal Development and Disease , 2011, Cell.

[4]  H. Steller,et al.  Programmed Cell Death in Animal Development and Disease , 2011, Cell.

[5]  G. P. Studzinski,et al.  c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D. , 2009, Leukemia research.

[6]  Daniel Nowak,et al.  Differentiation therapy of leukemia: 3 decades of development. , 2009, Blood.

[7]  P. Krammer,et al.  Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. , 2007, Blood.

[8]  P. Krammer,et al.  Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation , 2007, Cell Death and Differentiation.

[9]  Xuening Wang,et al.  Regulation of C/EBPβ isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3 , 2006 .

[10]  T. Caserta,et al.  Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties , 2003, Apoptosis.

[11]  G. P. Studzinski,et al.  Derivatives of Vitamins D2 and D3 Activate Three MAPK Pathways and Upregulate pRb Expression in Differentiating HL60 Cells , 2002, Cell cycle.